Tumour lysis syndrome: new territory for a familiar foe?

Br J Haematol. 2015 Jun;169(5):609-10. doi: 10.1111/bjh.13402. Epub 2015 Mar 30.

Authors

Emily Graves¹, Dominic Culligan²

Affiliations

¹ Department of Haematology, Newcastle-upon-Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
² Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, UK.

PMID: 25824526
DOI: 10.1111/bjh.13402

No abstract available

Keywords: biochemistry; chemotherapy; metabolism; renal failure.

Publication types

Editorial

MeSH terms

Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Humans
Neoplasms / complications
Neoplasms / drug therapy
Tumor Lysis Syndrome / etiology*

Substances

Antineoplastic Agents